Prasad Raju (CIK 1968317) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-24). Recent activity: Sell CRSP (3,708 shares), Buy CRSP (6,250 shares), Buy CRSP (10,000 shares), Buy CRSP (6,875 shares), Sell CRSP (5,848 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 3,708 | $173,460 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 6,250 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 10,000 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 6,875 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 5,848 | $282,224 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 4,021 | $194,053 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 750 | $0 |
| 2026-01-26 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 34,972 | $1.6M |
| 2026-01-26 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 34,972 | $2.1M |
| 2026-01-08 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 6,339 | $280,881 |
| 2026-01-08 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 23,361 | $1.1M |
| 2026-01-08 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 18,933 | $1.1M |
| 2026-01-08 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 5,004 | $300,240 |
| 2026-01-08 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 5,763 | $346,990 |
| 2025-12-23 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 3,528 | $194,393 |
| 2025-12-23 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 5,472 | $308,238 |
| 2025-12-23 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 1,000 | $56,890 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 6,250 | $0 |
| 2025-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 2,197 | $90,582 |
| 2025-03-18 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Buy | 10,000 | $0 |
| 2025-03-18 | CRISPR Therapeutics AG (CRSP) | Chief Financial Officer | Sell | 3,762 | $157,252 |
Source: SEC Form 4 filings · as of 2026-03-24